Abstract
The number of primary cutaneous lymphoma patients receiving low-dose radiotherapy is increasing, though controlled clinical trials defining the standard radiation dose for each specific entity have not yet been completed. Radiation oncologists are left with making highly individualized decisions that would be better enriched by additional clinical evidence. In this expert opinion, we aim to provide a clear recommendation to improve the current practice of radiation oncology. In addition, existing literature has been reviewed to develop recommendations for all types of primary cutaneous lymphoma. A prospective trial is urgently needed to identify the factors influencing patient outcomes following different radiation doses.
| Original language | English |
|---|---|
| Article number | 115064 |
| Pages (from-to) | 115064 |
| Journal | European Journal of Cancer |
| Volume | 212 |
| Early online date | 08 Oct 2024 |
| DOIs | |
| Publication status | Published - Nov 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Humans
- Lymphoma, T-Cell, Cutaneous/radiotherapy
- Mycosis Fungoides/radiotherapy
- Practice Guidelines as Topic
- Radiotherapy Dosage
- Skin Neoplasms/radiotherapy
- Radiation Oncology/standards
Fingerprint
Dive into the research topics of 'Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver